Tag: ultimately-help

Novartis's psoriasis drug Cosentyx showed long-term efficacy in keeping patients' skin clear, the Swiss drugmaker said on Saturday, citing a study it hopes will ultimately help the company to win business from rival medicines made by Amgen and Johnson & Johnson. More than 66 percent of Cosentyx patients achieved “clear or almost clear” skin after…